PharmTech Europe, Weekly Alert
Having trouble viewing this e-mail? CLICK HERE

PharmTech Europe
6 March 2018

PHARMTECH.COM

CURRENT ISSUE

SUBSCRIBE

FORWARD

twitter twitter
advertisement

Top Stories

Viewpoint: 2018 a Critical Year for Maturation of European Bio Supply Chain

As Europe’s growing biomanufacturing and bioprocessing industries develop, now a crucial time for the small-molecule and biopharma industries to integrate in order to facilitate growth.
/ read more /


Roche to Acquire Flatiron Health for $1.9 Billion

Roche will acquire oncology-focused healthcare technology and services company Flatiron Health for $1.9 billion to further its personalized oncological healthcare strategy.
/ read more /

advertisement
advertisement

Industry News

GSK Recalls Three Lots of Respiratory Inhalers in UK

GlaxoSmithKline has issued a voluntary recall of three lots of respiratory inhalers in the United Kingdom, including preventer and emergency relief inhalers.
/ read more /


Hospira Recalls Labetalol Hydrochloride Due to Cracked Vials

The company is voluntarily recalling three lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial and one lot of Labetalol Hydrochloride Injection, USP, Novaplus because of the potential of cracked glass at the rim of the vials.
/ read more /


More Industry News
advertisement

Regulatory News

FDA Publishes Q&A Document on ICH Q11

The agency clarifies recommendations found in ICH Q11 about chemical entities and biotechnology entities.
/ read more /


 

FDA Issues Guidance on Bioresearch Monitoring Content for NDAs and BLAs

The agency released draft guidance on the format for electronic submissions of NDA and BLA content regarding the planning of bioresearch monitoring inspections.
/ read more /


More Regulatory News

Bio/Pharma News

Merck & Co. Acquires Viralytics for $394 Million

Merck & Co. has acquired oncology-focused biopharmaceutical company Viralytics to strengthen Merck’s oncology pipeline.
/ read more /


Gilead Wins Reversal of $2.54-Billion Hep C Patent Verdict

A jury verdict requiring Gilead Sciences to pay $2.54 billion for patent infringement to competitor Merck & Co. over Gilead’s Harvoni (ledipasvir and sofosbuvir) and Sovaldi (sofosbuvir), two best-selling hepatitis C drugs, has been overturned.
/ read more /


More Bio/Pharma News

Supplier News

Samsung BioLogics Gets $148-Million Contract for New Manufacturing Plant

The contract development and manufacturing organization has entered it first manufacturing contract worth $148 million for its recently completed Plant 3 facility.
/ read more /


WuXi STA and Regulus Collaborate on microRNA Development and Manufacturing

The agreement follows the recent opening of WuXi STA’s oligonucleotide R&D labs in China and the US.
/ read more /


More Supplier News

FEATURED TOPICS

Outsourcing

Case Study: Fast-Track Technology Transfer of a Soft-Gelatin Capsule

Industry lessons from a fast-track technology transfer of a soft-gelatin capsule are multifold. This case study reviews the success factors for effective execution of the technology transfer
/ read more /

 

Drug Development

Accelerating Early Drug Development with Translational Pharmaceutics

Mark Egerton, PhD, chief executive officer of Quotient Sciences, shares insights on a new approach to accelerate drug development, which integrates formulation development, real-time adaptive GMP manufacturing, and clinical research within a single platform.
/ read more /

Dosage Forms

A Three-Step Path Toward Combination Product Approval

This article describes how to improve the regulatory journey from classification to market clearance for sponsors of medical device combination products.
/ read more /

Quality Systems

QbD and API Process Development: A Marriage of Chemistry and Engineering

Chemical engineers and chemists each bring unique skills to API process development and optimization. Success depends on their close collaboration, at both sponsor and CDMO facilities.
/ read more /


LIVE WEBCASTS

Top Quality Trends for 2018: Pharma Quality Survey Report
Live Webcast: Wednesday, March 7 at 11:00am EST
Register now


Successfully Progressing Therapeutic Candidates from Discovery to Development Using Early Developability Assessment Tools
Live Webcast: Wednesday, March 14 at 11:00am EDT
Register now


Real-Time Process Control for Healthy, High-Purity Water Systems
Live Webcast: Thursday, March 15 at 11:00am EDT
Register now


ON DEMAND WEBCAST

Assessing Product Integrity Risk Profiles and Engineering On-Dose Authentication During Drug Development Process
On Demand
Learn more


Events

9th Global Drug Delivery & Formulation Summit

Berlin, Germany

12–14 March 2018

Making Pharmaceuticals Europe 2018

Brussels, Belgium

13–14 March 2018

Paperless Lab Academy 2018

Milano, Italy

20–21 March 2018


more events

eBOOKS

Vaccines Development and Manufacturing 2017

Vaccines—from childhood and influenza immunizations, to epidemic prevention, to cancer and therapeutic treatments—present unique development challenges. In this Vaccine and Manufacturing eBook, the editors explore development and manufacturing options to make vaccines more accessible.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise